Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2000

View Archived Issues

Company Profile: Pharmasset

AVI BioPharma's oral Resten-NG enters phase I testing

Cimetidine as treatment for viral warts in children and adults

E-5842: a new antipsychotic agent with anxiolytic-like properties

Functional dopamine-antagonist activity reported for SR-142801, an NK3 antagonist

Celecoxib in familial adenomatous polyposis

Licensing opportunity from NIH: treating renal cell carcinoma with FGF-5

Cancer chemoresistance may be weakened by inhibitors of fibroblast growth factors

Visudyne approved in E.U. for treatment of wet AMD

Rapamune regulatory application receives negative opinion from CPMP

Egis reports advances in preclinical and clinical programs

Proposed merger of Glaxo Wellcome and SmithKline Beecham advances on schedule

Hemosol seeks approval of Hemolink in Canada

Millennium and Aventis initiate major strategic alliance

Three-way merger to form Curis approved

Oxigene completes phase I trials of declopramide

Proneuron initiates phase I trial in spinal cord injury

Growth protein linked to the learning process

Synthesis, activity and use of NK1/NK2 receptor antagonists reported by AstraZeneca

New Roche compounds inhibit amidolytic activity of factor VIIa/tissue factor complex

TPO mimetics identified as part of joint SB/Ligand program

Antisense compounds from Isis modulate the expression of Akt-1

AstraZeneca presents new compounds with antiischemic effects

Recently issued patent covers B-I's new heterocyclic PDE4 inhibitors

Research at AHP leads to identification of novel 5-HT2C agonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...